Literature DB >> 19520172

Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride.

Yoko Ikoma1, Hiroshi Watabe, Takuya Hayashi, Yoshinori Miyake, Noboru Teramoto, Kotaro Minato, Hidehiro Iida.   

Abstract

Positron emission tomography (PET) with [(11)C]raclopride is widely used to investigate temporal changes in the dopamine D(2) receptor system attributed to the dopamine release. The simplified reference tissue model (SRTM) can be used to determine the binding potential (BP(ND)) value using the time-activity curve (TAC) of the reference region as input function. However, in assessing temporal changes in BP(ND) using the SRTM, multiple [(11)C]raclopride PET scans are required, and a second scan must be performed after the disappearance of the [(11)C]raclopride administered in the first scan. In this study, we have developed an extended multiple-injection SRTM to estimate the BP(ND) change, from a single PET scan with multiple injections of [(11)C]raclopride, and we have validated this approach by performing numerous simulations and studies on monkeys. In the computer simulations, TACs were generated for dual injections of [(11)C]raclopride, in which binding conditions changed during the scans, and the BP(ND) values before, and after, the second injection were estimated by the proposed method. As a result, the reduction in BP(ND) was correlated, either with the integral of released dopamine, or with the administered mass of raclopride. This method was applied to studies on monkeys, and was capable of determining two identical BP(ND) values when there were no changes in binding conditions. The BP(ND) after the second injection decreased when binding conditions changed due to an increase in administered raclopride. An advantage of the proposed method is the shortened scan period for the quantitative assessment of the BP(ND) change for neurotransmitter competition studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520172     DOI: 10.1016/j.neuroimage.2009.05.099

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  9 in total

Review 1.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Selection of weighting factors for quantification of PET radioligand binding using simplified reference tissue models with noisy input functions.

Authors:  M D Normandin; R A Koeppe; E D Morris
Journal:  Phys Med Biol       Date:  2012-01-12       Impact factor: 3.609

3.  A linear model for estimation of neurotransmitter response profiles from dynamic PET data.

Authors:  Marc D Normandin; Wynne K Schiffer; Evan D Morris
Journal:  Neuroimage       Date:  2011-07-13       Impact factor: 6.556

4.  Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

Authors:  Diana Martinez; Kenneth M Carpenter; Fei Liu; Mark Slifstein; Allegra Broft; Alessandra Calvo Friedman; Dileep Kumar; Ronald Van Heertum; Herbert D Kleber; Edward Nunes
Journal:  Am J Psychiatry       Date:  2011-03-15       Impact factor: 18.112

5.  Measurement of density and affinity for dopamine D(2) receptors by a single positron emission tomography scan with multiple injections of [(11)C]raclopride.

Authors:  Yoko Ikoma; Hiroshi Watabe; Takuya Hayashi; Yoshinori Miyake; Noboru Teramoto; Kotaro Minato; Hidehiro Iida
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

6.  18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases.

Authors:  Timo Grimmer; Kuangyu Shi; Janine Diehl-Schmid; Bianca Natale; Alexander Drzezga; Stefan Förster; Hans Förstl; Markus Schwaiger; Igor Yakushev; Hans-Jürgen Wester; Alexander Kurz; Behrooz Hooshyar Yousefi
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 13.437

7.  In vivo assessment of HER2 receptor density in HER2-positive tumors by near-infrared imaging, using repeated injections of the fluorescent probe.

Authors:  Yasaman Ardeshirpour; Moinuddin Hassan; Rafal Zielinski; Jason A Horton; Jacek Capala; Amir H Gandjbakhche; Victor Chernomordik
Journal:  Technol Cancer Res Treat       Date:  2013-08-31

8.  Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission.

Authors:  Maarten Ooms; Sofie Celen; Ronald De Hoogt; Ilse Lenaerts; Johnny Liebregts; Greet Vanhoof; Xavier Langlois; Andrey Postnov; Michel Koole; Alfons Verbruggen; Koen Van Laere; Guy Bormans
Journal:  EJNMMI Radiopharm Chem       Date:  2016-03-21

9.  Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride.

Authors:  Yoko Ikoma; Yasuyuki Kimura; Makiko Yamada; Takayuki Obata; Tetsuya Suhara; Hiroshi Ito
Journal:  Front Psychiatry       Date:  2022-07-12       Impact factor: 5.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.